受强制性开放获取政策约束的文章 - William A. Lackington了解详情
无法在其他位置公开访问的文章：1 篇
The human L1 element: a potential biomarker in cancer prognosis, current status and future directions
O Piskareva, W Lackington, D Lemass, C Hendrick, P Doolan, N Barron
Current molecular medicine 11 (4), 286-303, 2011
强制性开放获取政策： Science Foundation Ireland
可在其他位置公开访问的文章：8 篇
Advances in nerve guidance conduit-based therapeutics for peripheral nerve repair
WA Lackington, AJ Ryan, FJ O’Brien
ACS Biomaterials Science & Engineering 3 (7), 1221-1235, 2017
强制性开放获取政策： Science Foundation Ireland, European Commission, Irish Research Council
A physicochemically optimized and neuroconductive biphasic nerve guidance conduit for peripheral nerve repair
AJ Ryan, WA Lackington, AJ Hibbitts, A Matheson, T Alekseeva, ...
Advanced Healthcare Materials 6 (24), 1700954, 2017
强制性开放获取政策： Science Foundation Ireland, European Commission, Irish Research Council
Controlling the dose-dependent, synergistic and temporal effects of NGF and GDNF by encapsulation in PLGA microparticles for use in nerve guidance conduits for the repair of …
WA Lackington, Z Kočí, T Alekseeva, AJ Hibbitts, SL Kneafsey, G Chen, ...
Journal of Controlled Release 304, 51-64, 2019
强制性开放获取政策： Science Foundation Ireland, European Commission, Irish Research Council
In vitro efficacy of a gene-activated nerve guidance conduit incorporating non-viral PEI-pDNA nanoparticles carrying genes encoding for NGF, GDNF and c-Jun
WA Lackington, RM Raftery, FJ O'Brien
Acta Biomaterialia 75, 115-128, 2018
强制性开放获取政策： Science Foundation Ireland, European Commission, Irish Research Council
Non-viral gene delivery of interleukin-1 Receptor antagonist using collagen-hydroxyapatite scaffold protects rat BM-MSCs from IL-1β-mediated inhibition of osteogenesis
WA Lackington, MA Gomez-Sierra, A González-Vázquez, FJ O’Brien, ...
Frontiers in bioengineering and biotechnology 8, 582012, 2020
强制性开放获取政策： European Commission
Incorporation of hydroxyapatite into collagen scaffolds enhances the therapeutic efficacy of rhBMP-2 in a weight-bearing femoral defect model
WA Lackington, D Gehweiler, I Zderic, D Nehrbass, S Zeiter, ...
Materials Today Communications 29, 102933, 2021
强制性开放获取政策： European Commission
Interleukin-1 receptor antagonist enhances the therapeutic efficacy of a low dose of rhBMP-2 in a weight-bearing rat femoral defect model
WA Lackington, D Gehweiler, E Zhao, I Zderic, D Nehrbass, S Zeiter, ...
Acta Biomaterialia 149, 189-197, 2022
强制性开放获取政策： European Commission
Characterization and biological evaluation of 3D printed composite ink consisting of collagen, hyaluronic acid and calcium phosphate for bone regeneration
D Van der Heide, LP Hatt, E Della Bella, A Hangartner, WA Lackington, ...
Carbohydrate Polymer Technologies and Applications 7, 100518, 2024
强制性开放获取政策： European Commission
出版信息和资助信息由计算机程序自动确定